Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Figure 1.

Description and explanations of antiretroviral regimens used for analysis.

*sdNVP: single dose of nevirapine for the mother taken at the onset of labor and a single dose of nevirapine for the infant administered within 72 hours of delivery. **Due to low patient numbers in each individual grouping, these suboptimal interventions were grouped together. ***Based on 2006 WHO PMTCT guidelines. Abbreviations: ARV (antiretroviral), ART (antiretroviral therapy), AZT (zidovudine).

More »

Figure 1 Expand

Figure 2.

Outcomes for HIV-infected pregnant women and HIV-exposed infants enrolled in the Tingathe program.

After the maternal deaths, all five infants were transferred to the care of another caregiver and moved out of the program catchment area.

More »

Figure 2 Expand

Table 1.

Characteristics of 1088 HIV positive pregnant women at enrollment in the Tingathe program.

More »

Table 1 Expand

Figure 3.

Antiretroviral regimen by trimester at enrollment.

aFor explanations of ARV regimen categories please refer to Figure 1. Abbreviations: ART (antiretroviral therapy), ARV (antiretroviral).

More »

Figure 3 Expand

Table 2.

Vertical HIV transmission rates at first PCR by antiretroviral regimen.

More »

Table 2 Expand

Table 3.

Characteristics of women and infants associated with positive first PCR versus negative first PCR.

More »

Table 3 Expand

Table 4.

Descriptions of WHO Option A, B, and B+.

More »

Table 4 Expand